Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTAGE family member 12, pseudogene (CTAGE12P) is identified as a pseudogene located on human chromosome 9 (hg38: chr9:27608382-27610745)[1][3]. As a pseudogene, CTAGE12P is a genomic DNA sequence similar to a functional gene but rendered nonfunctional due to accumulated mutations that prevent proper protein coding[2][5]. CTAGE12P does not encode a protein and is not classified as a receptor, enzyme, transporter, transcription factor, or other standard molecular drug target class[1][3]. Current databases do not recognize it as a therapeutic target, and there are no reports linking it to drug interactions, mechanisms of drug action, use as a biomarker, or specific safety concerns. While pseudogenes in general can sometimes play roles in gene regulation or disease (for example, as competitive endogenous RNAs or sources of regulatory transcripts[4][5]), there is no evidence for such a function in the case of CTAGE12P. Because CTAGE12P is a pseudogene, it is not a valid drug target and should be marked as "incorrect" when validating therapeutic target lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTAGE family member 12, pseudogene (CTAGE12P).